Cologne Cohort of Neutropenic Patients (CoCoNut)
NCT01821456 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000
Last updated 2013-04-01
Summary
The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.
Conditions
- Hematological Malignancies
- Cancer
- Chemotherapy
- Neutropenia
- Immunosuppression
Interventions
- DRUG
-
Antiinfectives
To analyze to efficacy of (novel) drug therapies
Sponsors & Collaborators
-
University Hospital of Cologne
lead OTHER
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1995-01-31
- Primary Completion
- 2050-12-31
- Completion
- 2050-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
NCT07016165 ·Status: RECRUITING ·Phase: PHASE4
-
Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.
NCT04382508 ·Status: UNKNOWN
-
COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity
NCT04690114 ·Status: UNKNOWN
-
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
NCT05315583 ·Status: TERMINATED ·Phase: NA
-
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759 ·Status: COMPLETED
-
Antimicrobial Susceptibility Patterns of N. Gonorrhea Isolates in an Era of Quinolone Resistance
NCT00692822 ·Status: COMPLETED
-
Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19
NCT04534712 ·Status: COMPLETED
-
The CHILD Cohort COVID-19 Add-On Study
NCT05234359 ·Status: COMPLETED
-
Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member
NCT04649944 ·Status: UNKNOWN
-
Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection
NCT04594785 ·Status: UNKNOWN
-
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19
NCT04418206 ·Status: COMPLETED ·Phase: NA
-
Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea
NCT05027516 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effectiveness of a Laboratory Intervention to Effectively NOT Treat Asymptomatic Bacteriuria
NCT03445312 ·Status: COMPLETED
-
Coronavirus Pediatric Serological Study
NCT05128435 ·Status: COMPLETED
-
ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19
NCT04367740 ·Status: COMPLETED
-
Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection
NCT00450632 ·Status: COMPLETED
-
A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection
NCT04254991 ·Status: UNKNOWN
-
Rapid Strep Test Results
NCT04256694 ·Status: UNKNOWN
-
Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen
NCT04707833 ·Status: TERMINATED ·Phase: NA
-
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
NCT04588363 ·Status: COMPLETED
-
C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.
NCT04935515 ·Status: COMPLETED ·Phase: NA
-
Rutgers COVID-19 Cohort Study
NCT04336215 ·Status: COMPLETED
-
TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2
NCT05195060 ·Status: COMPLETED
-
Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.
NCT04596098 ·Status: COMPLETED
-
Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024
NCT06683937 ·Status: NOT_YET_RECRUITING